This is a Validated Antibody Database (VAD) review about mouse Ciita, based on 3 published articles (read how Labome selects the articles), using Ciita antibody in all methods. It is aimed to help Labome visitors find the most suited Ciita antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ciita synonym: C2ta; EG669998; Gm9475; Mhc2ta

Santa Cruz Biotechnology
mouse monoclonal (7-1H)
  • western blot; human; fig 2d
Santa Cruz Biotechnology Ciita antibody (Santa Cruz, sc-13556) was used in western blot on human samples (fig 2d). Oncoimmunology (2022) ncbi
mouse monoclonal
  • western blot; human; 1:1000; loading ...; fig 1
Santa Cruz Biotechnology Ciita antibody (Santa Cruz, 7-1H) was used in western blot on human samples at 1:1000 (fig 1). Front Immunol (2017) ncbi
mouse monoclonal (7-1H)
  • western blot; human; 1:1000; loading ...; fig 1
Santa Cruz Biotechnology Ciita antibody (Santa Cruz, 7-1H) was used in western blot on human samples at 1:1000 (fig 1). Front Immunol (2017) ncbi
mouse monoclonal (7-1H)
  • immunoprecipitation; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology Ciita antibody (SantaCruz, 7-1H) was used in immunoprecipitation on human samples (fig 2c) and in western blot on human samples (fig 2c). J Transl Med (2016) ncbi
mouse monoclonal
  • immunoprecipitation; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology Ciita antibody (SantaCruz, 7-1H) was used in immunoprecipitation on human samples (fig 2c) and in western blot on human samples (fig 2c). J Transl Med (2016) ncbi
Articles Reviewed
  1. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed publisher
  2. Forlani G, Tosi G, Turrini F, Poli G, Vicenzi E, Accolla R. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1. Front Immunol. 2017;8:564 pubmed publisher
  3. Forlani G, Turrini F, Ghezzi S, Tedeschi A, Poli G, Accolla R, et al. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells. J Transl Med. 2016;14:94 pubmed publisher